Apinya Ngam-ek

930 total citations
7 papers, 701 citations indexed

About

Apinya Ngam-ek is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Apinya Ngam-ek has authored 7 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in Apinya Ngam-ek's work include Monoclonal and Polyclonal Antibodies Research (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Response and Inflammation (3 papers). Apinya Ngam-ek is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Response and Inflammation (3 papers). Apinya Ngam-ek collaborates with scholars based in United States and Canada. Apinya Ngam-ek's co-authors include Jeffrey L. Browning, Jane Hunt, Roy A. Fava, Steven Perrin, Norm Allaire, P Bourdon, Konrad Miatkowski, Werner Meier, Irene Sizing and Catherine Hession and has published in prestigious journals such as Journal of Clinical Investigation, Immunity and The Journal of Immunology.

In The Last Decade

Apinya Ngam-ek

7 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Apinya Ngam-ek United States 6 580 144 108 75 65 7 701
R K Lee United States 8 398 0.7× 88 0.6× 91 0.8× 45 0.6× 49 0.8× 10 640
Shuji Kaga Japan 11 329 0.6× 103 0.7× 125 1.2× 33 0.4× 50 0.8× 18 571
Paola Pittoni Italy 12 571 1.0× 170 1.2× 125 1.2× 37 0.5× 31 0.5× 13 689
Yumiko Kanno Japan 12 464 0.8× 64 0.4× 112 1.0× 90 1.2× 39 0.6× 19 624
Caroline E. Zuber France 8 417 0.7× 187 1.3× 124 1.1× 31 0.4× 38 0.6× 8 624
Beatrix Metzner Germany 10 341 0.6× 188 1.3× 106 1.0× 35 0.5× 70 1.1× 14 545
Christopher Eichman United States 10 300 0.5× 117 0.8× 187 1.7× 44 0.6× 85 1.3× 12 565
Zhuoru Liu United States 19 929 1.6× 113 0.8× 116 1.1× 60 0.8× 68 1.0× 25 1.2k
Beverley Wilkinson United States 8 465 0.8× 215 1.5× 153 1.4× 33 0.4× 44 0.7× 8 638
S. M. Shahjahan Miah United States 18 393 0.7× 128 0.9× 267 2.5× 61 0.8× 32 0.5× 23 665

Countries citing papers authored by Apinya Ngam-ek

Since Specialization
Citations

This map shows the geographic impact of Apinya Ngam-ek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Apinya Ngam-ek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Apinya Ngam-ek more than expected).

Fields of papers citing papers by Apinya Ngam-ek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Apinya Ngam-ek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Apinya Ngam-ek. The network helps show where Apinya Ngam-ek may publish in the future.

Co-authorship network of co-authors of Apinya Ngam-ek

This figure shows the co-authorship network connecting the top 25 collaborators of Apinya Ngam-ek. A scholar is included among the top collaborators of Apinya Ngam-ek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Apinya Ngam-ek. Apinya Ngam-ek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Browning, Jeffrey L., Norm Allaire, Apinya Ngam-ek, et al.. (2005). Lymphotoxin-β Receptor Signaling Is Required for the Homeostatic Control of HEV Differentiation and Function. Immunity. 23(5). 539–550. 213 indexed citations
2.
Gommerman, Jennifer L., Keith Giza, Stuart J. Perper, et al.. (2003). A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. Journal of Clinical Investigation. 112(5). 755–767. 51 indexed citations
3.
Fava, Roy A., Jane Hunt, Nora Ratcliffe, et al.. (2003). A Role for the Lymphotoxin/LIGHT Axis in the Pathogenesis of Murine Collagen-Induced Arthritis. The Journal of Immunology. 171(1). 115–126. 99 indexed citations
4.
Gommerman, Jennifer L., Keith Giza, Stuart J. Perper, et al.. (2003). A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. Journal of Clinical Investigation. 112(5). 755–767. 4 indexed citations
5.
Browning, Jeffrey L., Irene Sizing, P Bourdon, et al.. (1997). Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. The Journal of Immunology. 159(7). 3288–3298. 161 indexed citations
6.
Mackay, Fabienne, P Bourdon, David Griffiths, et al.. (1997). Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes. The Journal of Immunology. 159(7). 3299–3310. 37 indexed citations
7.
Browning, Jeffrey L., Irene Dougas, Apinya Ngam-ek, et al.. (1995). Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.. The Journal of Immunology. 154(1). 33–46. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026